Read + Share
Amedeo Smart
Independent Medical Education
Mill CP, Fiskus W, DiNardo CD, Birdwell C, et al. Effective therapy for AML with RUNX1 mutation by cotreatment with inhibitors of protein translation and BCL2. Blood 2022;139:907-921.PMID: 34601571
Email
LinkedIn
Facebook
Twitter
Privacy Policy